NEWS & INTELLIGENCE

  • All
  • News
  • White papers

Reference Safety Information in Clinical Trials

The Reference Safety Information (RSI) section of an Investigator’s Brochure (IB) is an important document that can be a subject of audits and regulatory inspections. …

Soterius, Inc. Moves to Bigger Offices to Support Rapid Growth and Enhanced Client Services

Soterius, Inc., a global provider of cutting-edge safety and medical affairs services and solutions, today announced its move to a new, significantly larger business premises …

Meet Soterius at the DIA Pharmacovigilance and Risk Management Strategies Conference in Washington

Soterius will be exhibiting at the DIA Pharmacovigilance and Risk Management Strategies Conference in Washington, DC from January 27-29 at booth #15. Stop by to …

Soterius and Celegence Announce a Global Partnership and Investment

Soterius and Celegence are pleased to announce that as a part of Soterius’ Series A financing round, Celegence Holdings LLC has made a significant strategic …

MAIA Pharmaceuticals Announces Soterius As Its Trusted Partner

We are delighted to support MAIA Pharmaceuticals with their regulatory strategy and operations for filings in Europe for a very important project which should mark …

Evolving Role of MSLs

The role of Medical Science Liaisons (MSLs) has evolved over the past decade. Advances in medical science ranging from immunotherapy to targeted therapies which can …

Soterius for Breast Cancer

October is the breast cancer awareness month, a worldwide campaign to educate and support awareness about breast cancer and the importance of its early detection. …

Soterius to present at Aris Global Life Sciences Technology Summit 2019

We are excited to announce that Soterius’ CEO, Suneet Walia, will be speaking on the topic of “Speed to Market: ISP-Based Safety Implementation” along with …

Book Launch at DIA 2019 Global Annual Meeting, San Diego

Soterius is pleased to host the launch of Bart Cobert’s Manual of Drug Safety and Pharmacovigilance, 3rd edition at booth #2631 on June 26, 8.30am …

Meet Soterius at the DIA Global Annual Meeting in San Diego

Soterius will be exhibiting at the Global Annual 2019 Meeting in San Diego from June 24-26 at booth #2631. Stop by to learn more about …

Top 5 Global Pharma Company Trusts Soterius with Providing Time-Sensitive Medical and Scientific Services

We are pleased to announce that we have started delivering highly sensitive medical and scientific services for one of the leading pharma companies in the …

Soterius Expands US Operations

We are pleased to announce the expansion of our services across the US. Our office is established in Princeton, NJ, and we operate as a …

Soterius will attend World Drug Safety Congress – Europe

http://www.terrapinn.com/conference/world-drug-safety-congress-europe/index.stm Soterius staff will attend and will be available for meeting with professionals attending this meeting on September 10 and 11, 2018. Please use the …

Soterius appoints its first CEO

Soterius is pleased to announce the appointment of its first Chief Executive Officer, Suneet Walia. Suneet is a business leader and an entrepreneur with more …

Soterius appoints Dr. Sumit Verma, MD, DNB to lead operations

Soterius, the best-in-class outsourced safety, medical affairs, regulatory, and technology services company announced today that Dr. Sumit Verma, MD, DNB has joined the company as …

Soterius : What does it mean ? When did it begin ?

Soterius originates from Indo – Greek mythology. Soter (Σωτήρ “Saviour, Deliverer”) was the personification or daimon of safety, preservation and deliverance from harm. How fitting …

What Can We Do For You?

Get the latest presentation of our service capabilities and technology assets.

Scroll to Top